1. Home
  2. PANL vs ARVN Comparison

PANL vs ARVN Comparison

Compare PANL & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pangaea Logistics Solutions Ltd.

PANL

Pangaea Logistics Solutions Ltd.

N/A

Current Price

$8.82

Market Cap

533.6M

ML Signal

N/A

Logo Arvinas Inc.

ARVN

Arvinas Inc.

N/A

Current Price

$6.89

Market Cap

600.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PANL
ARVN
Founded
1996
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.6M
600.2M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
PANL
ARVN
Price
$8.82
$6.89
Analyst Decision
Strong Buy
Buy
Analyst Count
3
15
Target Price
$10.85
★ $14.00
AVG Volume (30 Days)
355.6K
★ 864.0K
Earning Date
11-05-2026
11-03-2026
Dividend Yield
★ 4.68%
N/A
EPS Growth
N/A
★ 58.84
EPS
★ 0.95
0.88
Revenue
★ $385,088,209.00
$262,600,000.00
Revenue This Year
$17.93
$5.67
Revenue Next Year
N/A
N/A
P/E Ratio
$8.97
★ $7.87
Revenue Growth
★ N/A
N/A
52 Week Low
$6.21
$6.33
52 Week High
$9.39
$14.22

Technical Indicators

Market Signals
Indicator
PANL
ARVN
Relative Strength Index (RSI) 67.18 43.22
Support Level $7.81 $6.74
Resistance Level $9.27 $7.85
Average True Range (ATR) 0.36 0.48
MACD 0.11 -0.04
Stochastic Oscillator 90.68 32.65

Price Performance

Historical Comparison
PANL
ARVN

About PANL Pangaea Logistics Solutions Ltd.

Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: